Moleculin Biotech Inc., of Houston, engaged Bioscience SA, a contract research organization based in Bydgoszcz, Poland, to prepare a proof-of-concept trial in Poland for Moleculin's WP-1220 in patients with cutaneous T-cell lymphoma. Moleculin has completed the IND-enabling studies and plans to make an application to the Polish regulators soon.